Aspirin may reduce risk of ovarian cancer by 20 percent
Daily use of aspirin may reduce a woman’s risk of ovarian cancer risk by as much as 20 percent, according to research published yesterday by scientists at the National Cancer Institute. Scientists evaluated data from 12 previously published studies and found women who took aspirin regularly had a 20 percent lower rate of ovarian cancer, while women who took other NSAID pain relievers had a 10 percent lower risk. Use of acetaminophen, the active drug in Tylenol, had no effect. However, before you begin a daily aspirin regimen, researchers caution that more research is needed before clinical recommendations are changed.
Read more about the study here.